chr12-49026823-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003482.4(KMT2D):c.15143G>A(p.Arg5048His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5048C) has been classified as Pathogenic.
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KMT2D | NM_003482.4 | MANE Select | c.15143G>A | p.Arg5048His | missense | Exon 49 of 55 | NP_003473.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KMT2D | ENST00000301067.12 | TSL:5 MANE Select | c.15143G>A | p.Arg5048His | missense | Exon 49 of 55 | ENSP00000301067.7 | ||
| KMT2D | ENST00000683543.2 | c.15143G>A | p.Arg5048His | missense | Exon 49 of 56 | ENSP00000506726.1 | |||
| KMT2D | ENST00000685166.1 | c.15152G>A | p.Arg5051His | missense | Exon 48 of 54 | ENSP00000509386.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Kabuki syndrome 1 Pathogenic:6
This missense KMT2D variant at c.15143G>A (p.R5048H) was discovered on exome through the Texome Project (R01HG011795). This variant has been reported in individuals with Kabuki syndrome 1 (PMID: 3913813, 27302555, 28475860, 29304373, 30459467). This variant has not been observed in gnomAD (PM2) and is predicted to be deleterious by multiple computational models (CADD: 31.000) (PP3). The evolutionary conservation of this residue is high. We classify this variant as pathogenic.
PS3_strong;PS4_moderate;PM1_moderate;PM2_supporting;PP4_supporting
Absent from controls (or at extremely low frequency if recessive) in Genome Aggregation Database, Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.;Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc).;Missense variant in a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease.;De novo (both maternity and paternity confirmed) in a patient with the disease and no family history.;The prevalence of the variant in affected individuals is significantly increased compared to the prevalence in controls.
not provided Pathogenic:2
Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in a patients with Kabuki syndrome in published literature (Miyake et al., 2013; Makrythanasis et al., 2013; Bogershausen et al., 2016); This variant is associated with the following publications: (PMID: 23320472, 23913813, 29304373, 28475860, 30459467, 27302555)
KMT2D: PS2:Very Strong, PM2, PM5, PS4:Moderate, PP3
Kabuki syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg5048 amino acid residue in KMT2D. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27302555). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KMT2D protein function. ClinVar contains an entry for this variant (Variation ID: 280132). This missense change has been observed in individual(s) with clinical features of Kabuki syndrome (PMID: 23913813, 27302555, 28475860). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 5048 of the KMT2D protein (p.Arg5048His).
KMT2D-related disorder Pathogenic:1
The KMT2D c.15143G>A variant is predicted to result in the amino acid substitution p.Arg5048His. This is a recurrent de novo variant that is reported to be causative for Kabuki Syndrome (Miyake et al. 2013. PubMed ID: 23913813; Butcher et al. 2017. PubMed ID: 28475860; Aref-Eshghi et al. 2018. PubMed ID: 29304373). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Furthermore, an alternate nucleotide change affecting the same amino acid (p.Arg5048Cys) has also been reported to be causative for Kabuki Syndrome (Hannibal et al. 2011. PubMed ID: 21671394). In summary, the c.15143G>A (p.Arg5048His) variant is interpreted as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at